Top

Intensive Care Medicine

Published in:

01-09-2016 | Correspondence

Ventilation-associated pneumonia and probiotics: many clues do not make evidence. Response to comments by Colombo and Codazzi

Authors: Juan Zeng, Chun-Ting Wang

Published in: Intensive Care Medicine | Issue 9/2016

Excerpt

Dear Editor, …

Timsit JF, Perner A, Bakker J, Bassetti M, Benoit D, Cecconi M et al (2015) Year in review in Intensive Care Medicine 2014: III. Severe infections, septic shock, healthcare-associated infections, highly resistant bacteria, invasive fungal infections, severe viral infections, Ebola virus disease and paediatrics. Intensive Care Med 41:575–588. doi:10.1007/s00134-015-3755-8 CrossRefPubMedPubMedCentral

Zeng J, Wang CT, Zhang FS et al (2016) Effect of probiotics on the incidence of ventilator-associated pneumonia in critically ill patients: a randomized controlled multicenter trial. Intensive Care Med. doi:10.1007/s00134-016-4303-x

Fàbregas N, Ewig S, Torres A, El-Ebiary M, Ramirez J, de La Bellacasa JP et al (1999) Clinical diagnosis of ventilator associated pneumonia revisited: comparative validation using immediate post-mortem lung biopsies. Thorax 54:867–873. doi:10.1136/thx.54.10.867 CrossRefPubMedPubMedCentral

Ego A, Preiser JC, Vincent JL (2015) Impact of diagnostic criteria on the incidence of ventilator-associated pneumonia. Chest 147:347–355. doi:10.1378/chest.14-0610 CrossRefPubMed

Jain PK, McNaught CE, Anderson ADG, MacFie J, Mitchell CJ (2004) Influence of synbiotic containing Lactobacillus acidophilus La5, Bifidobacterium lactis Bb 12, Streptococcus thermophilus, Lactobacillus bulgaricus and oligofructose on gut barrier function and sepsis in critically ill patients: a randomised controlled trial. Clin Nutr 23:467–475. doi:10.1016/j.clnu.2003.12.002 CrossRefPubMed

Jacobi CA, Schulz C, Malfertheiner P (2011) Treating critically ill patients with probiotics: beneficial or dangerous? Gut Pathog 3:2. doi:10.1186/1757-4749-3-2 CrossRefPubMedPubMedCentral

Blot S, Torres A, Francois B (2016) Evidence in the eye of the beholder: about probiotics and VAP prevention. Intensive Care Med. doi:10.1007/s00134-016-4353-0

Title: Ventilation-associated pneumonia and probiotics: many clues do not make evidence. Response to comments by Colombo and Codazzi
Authors: Juan Zeng
Chun-Ting Wang
Publication date: 01-09-2016
Publisher: Springer Berlin Heidelberg
Published in: Intensive Care Medicine / Issue 9/2016
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI: https://doi.org/10.1007/s00134-016-4395-3

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Ventilation-associated pneumonia and probiotics: many clues do not make evidence. Response to comments by Colombo and Codazzi

Excerpt

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 9/2016

Erratum to: Continuous renal replacement therapy versus intermittent hemodialysis in intensive care patients: impact on mortality and renal recovery

Community-acquired pneumonia related to intracellular pathogens

Tight glycemic control in acutely ill patients: low evidence of benefit, high evidence of harm!

Quantifying unintended exposure to high tidal volumes from breath stacking dyssynchrony in ARDS: the BREATHE criteria

The feasibility and safety of extracorporeal carbon dioxide removal to avoid intubation in patients with COPD unresponsive to noninvasive ventilation for acute hypercapnic respiratory failure (ECLAIR study): multicentre case–control study

Determinants of time to death in hospital in critically ill patients around the world